#TransMedics

@newsen.bsky.social

2 weeks ago

TransMedics Updates on Valuation Allowance Release Impacting Fourth Quarter Results TransMedics Group, Inc. provided insights on the effects of releasing a $103.3 million U.S. tax valuation allowance, impacting their fourth-quarter financial results significantly.

TransMedics Updates on Valuation Allowance Release Impacting Fourth Quarter Results #USA #TransMedics #TMDX #organ_transplant #Andover,_Massachusetts

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

2 weeks ago

TransMedics Announces Impressive Q4 and Full Year 2025 Financial Performance and Growth Plans TransMedics Group, Inc. reports significant financial growth for Q4 and full year 2025. The company outlines future growth strategies aiming to enhance organ transplant therapies.

TransMedics Announces Impressive Q4 and Full Year 2025 Financial Performance and Growth Plans #United_States #TransMedics #Andover #organ_transplant #OCS_NOP

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

3 weeks ago

TransMedics Group Unveils Significant Inducement Stock Grants for New Employees TransMedics Group, Inc. has announced the granting of stock options and restricted stock units to new employees, enhancing its talent acquisition strategy.

TransMedics Group Unveils Significant Inducement Stock Grants for New Employees #United_States #stock_options #TransMedics #Andover #organ_transplant

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

1 month ago

TransMedics Secures Unconditional FDA IDE Approval for OCS Heart Trial TransMedics Group, Inc. has received full FDA IDE approval for its OCS Heart ENHANCE trial, aiming to transform heart transplant procedures and patient outcomes.

TransMedics Secures Unconditional FDA IDE Approval for OCS Heart Trial #USA #FDA_Approval #TransMedics #Andover #OCS_Heart

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

2 months ago

TransMedics Unveils Expansion Plans with New Global Headquarters in Somerville TransMedics announces its new global headquarters at Assembly Innovation Park, signifying a major leap in organ transplant innovation and job creation.

TransMedics Unveils Expansion Plans with New Global Headquarters in Somerville #United_States #Somerville #TransMedics #organ_transplant

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

2 months ago

TransMedics Group Provides Inducement Grants to New Employees Under Listing Rule TransMedics Group, a leader in organ transplant technology, has granted inducement stock options to new employees, enhancing their commitment to innovative solutions.

TransMedics Group Provides Inducement Grants to New Employees Under Listing Rule #USA #stock_options #TransMedics #Andover #TMDX

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

3 months ago

TransMedics to Highlight Innovative Organ Transplant Solutions at Upcoming Healthcare Conference TransMedics will showcase its groundbreaking organ transplant technology at the Piper Sandler Healthcare Conference, enhancing organ transplant therapy.

TransMedics to Highlight Innovative Organ Transplant Solutions at Upcoming Healthcare Conference #United_States #New_York #healthcare #TransMedics #organ_transplant

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

4 months ago

TransMedics Announces Employee Stock Options and Grant Under NASDAQ Rule 5635(c)(4) TransMedics Group, Inc. has granted significant stock options and restricted stock units as an employee incentive, enhancing their commitment to organ transplant therapy.

TransMedics Announces Employee Stock Options and Grant Under NASDAQ Rule 5635(c)(4) #USA #NASDAQ #TransMedics #Andover #organ_transplant

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

4 months ago

TransMedics Achieves Significant Growth in Q3 2025 With Focus on Innovative Organ Transplant Solutions TransMedics Group, Inc. reports remarkable financial results for Q3 2025, signaling significant advancements in organ transplant therapies and collaborations.

TransMedics Achieves Significant Growth in Q3 2025 With Focus on Innovative Organ Transplant Solutions #USA #Q3_2025 #TransMedics #Andover #organ_transplant

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

5 months ago

TransMedics and Mercedes-Benz Collaborate to Transform Organ Transplant Logistics in Italy TransMedics and Mercedes-Benz have partnered to create a dedicated organ transplantation transport network across Italy, enhancing donor organ utilization.

TransMedics and Mercedes-Benz Collaborate to Transform Organ Transplant Logistics in Italy #Italy #Milan #TransMedics #Mercedes-Benz #organ_transport

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

5 months ago

TransMedics and Mercedes-Benz Join Forces to Revolutionize Organ Transport in Italy TransMedics and Mercedes-Benz unveil a groundbreaking partnership to establish Italy's first dedicated organ transplantation transport network, enhancing access to donor organs.

TransMedics and Mercedes-Benz Join Forces to Revolutionize Organ Transport in Italy #Italy #Milan #TransMedics #Mercedes-Benz #organ_transport

0 0 0 0

@kx1t-test.bsky.social

6 months ago

Planefence ICAO: A30615
Flt: N294TX TRANSMEDICS
First seen: 2025-09-09 23:12:41 EDT
Min Alt: 741 ft AGL
Min Dist: 0.89 nm
Peak Audio: -46 dBFS
Loudness: -1 dB
dev adsb planefence by kx1t - airplanes.live - planefence

0 0 0 0

WealthWise

@wealthwise-dca.bsky.social

7 months ago

TransMedics Group shares rose after the FDA granted conditional approval for a clinical trial of its Next-Generation OCS ENHANCE Heart system, designed to improve organ preservation for transplants.

#TMDX #TMDXStock #TMDXNews #TMDXStockNews #TransMedics #TransMedicsStock #TransMedicsNews

1 0 0 0

Profit Trading USA

@profittradingusa.bsky.social

7 months ago

TransMedics stock surges after FDA grants conditional approval for heart trial Investing.com -- TransMedics Group Inc (NASDAQ:TMDX) stock jumped 6.7% after the company announced that the U.S. Food and Drug Administration (FDA) has granted conditional approval for its Investigational Device Exemption (IDE), allowing it to proceed with its Next-Generation OCS ENHANCE Heart trial. The ENHANCE trial will be conducted in two parts, with Part A designed to support prolonged heart perfusion using the OCS Heart System, while Part B aims to demonstrate the superiority of OCS Heart perfusion in donation after brain death cases compared to static cold storage methods. The total sample size for both parts is expected to exceed 650 patients, which TransMedics believes would make it the largest heart preservation for transplant trial worldwide. "The recent FDA approvals to initiate our Next-Gen OCS ENHANCE Heart and DENOVO Lung trials mark key milestones in our ongoing commitment to transforming the standard of care and address the major clinical needs of the cardiothoracic transplant community," said Waleed Hassanein, MD, President and Chief Executive Officer. TransMedics plans to initiate both trials in the fourth quarter of 2025 while continuing to work with the FDA to address remaining questions related to pre-clinical testing. The company hopes these trials will drive clinical adoption for both heart and lung transplant technologies throughout 2026 and beyond. The Nasdaq-listed medical technology company focuses on transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure through its Organ Care System (OCS) technology. This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Click Subscribe #TransMedics #FDAApproval #HeartTrial #Investing #StockMarket

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

7 months ago

TransMedics Secures FDA Approval to Launch OCS Heart Trial Revolutionizing Transplant Therapy TransMedics has received FDA IDE approval to proceed with its groundbreaking OCS ENHANCE Heart trial, aimed at improving organ transplant methods.

TransMedics Secures FDA Approval to Launch OCS Heart Trial Revolutionizing Transplant Therapy #United_States #FDA_Approval #TransMedics #Andover #OCS_Heart

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

7 months ago

TransMedics Announces New Employee Inducement Grants Under NASDAQ Rule 5635 TransMedics Group, Inc. recently reported the granting of stock options and restricted stock units to new employees, fulfilling NASDAQ's inducement requirements.

TransMedics Announces New Employee Inducement Grants Under NASDAQ Rule 5635 #USA #NASDAQ #TransMedics #Andover #TMDX

0 0 0 0

WealthWise

@wealthwise-dca.bsky.social

7 months ago

TransMedics CEO Waleed Hassanein emphasized long-term growth, stating, “We are already ramping up our investments to drive the next several waves of growth that will deliver substantially more top and bottom line growth.”

#TMDX #TransMedics #TMDXStock #TMDXNews #TMDXStockNews
$TMDX

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

7 months ago

TransMedics Reports Strong Financial Growth in Q2 2025 with Increased Revenue and New Innovations TransMedics Group, Inc. announces impressive Q2 2025 financial results, highlighting a 38% revenue increase and new innovations in organ transplant therapy.

TransMedics Reports Strong Financial Growth in Q2 2025 with Increased Revenue and New Innovations #United_States #TransMedics #Andover #Organ_Care_System #NOP_Program

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

9 months ago

TransMedics Grants Inducement Options Enhancing Employee Incentives Under NASDAQ Rule 5635(c)(4) TransMedics Group, Inc. has announced the granting of stock options and restricted stock units to bolster employee retention and incentivize performance, successfully aligning with NASDAQ rules.

TransMedics Grants Inducement Options Enhancing Employee Incentives Under NASDAQ Rule 5635(c)(4) #United_States #TransMedics #Andover #TMDX #Organs

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

9 months ago

TransMedics Announces Participation in June Investor Conferences Focused on Organ Transplant Innovations TransMedics Group, Inc. reveals plans to attend two major investor conferences in June 2025, highlighting its advancements in organ transplantation technology.

TransMedics Announces Participation in June Investor Conferences Focused on Organ Transplant Innovations #United_States #investor_conference #TransMedics #Andover #organ_transplant

0 0 0 0

Thiard News@F4F

@newsen.bsky.social

10 months ago